Eli Lilly Taps Seamless Therapeutics in $1.12 BB Hearing Loss Gene-Editing Collaboration
DRESDEN, GERMANY & LEXINGTON, MASS – January 29, 2026 – A significant global research collaboration and licensing agreement has been announced between Seamless Therapeutics, a pioneering German gene-editing company, and…
